Total trials
43
Active
19
Phase 3
1
Total enrollment
10,161
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Canoderm | — | — | — | — | — | 1 | |
| Oviderm | — | — | — | — | — | 1 | |
| Decubal | — | — | — | — | — | 1 | |
| Clobetasol Propionate | — | — | — | — | — | 1 | |
| IPS e.max CAD, Ivoclar Vivadent | — | — | — | — | — | 1 | |
| BruxZir, Glidewell | — | — | — | — | — | 1 | |
| BruxZir*, Glidewell | — | — | — | — | — | 1 |
Next readouts
- 2020-02-01
- 2024-07-03
- 2025-11-07
Top conditions
- Pain3
- Peri-Implantitis3
- Tooth Extraction2
- Attitude2
- Caries2
- Dental Implant Failure2
- Periodontal Bone Loss2
- Burning Mouth Syndrome2
Frequently asked questions about Malmö University
- How many clinical trials does Malmö University have on ClinicalTrials.gov?
- Malmö University is listed as the lead sponsor on 43 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Malmö University's trials are in Phase 3?
- 1 of Malmö University's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Malmö University focus on?
- Malmö University's most-studied conditions on ClinicalTrials.gov are Pain, Peri-Implantitis, Tooth Extraction, Attitude, Caries.
- When are Malmö University's next clinical trial readouts?
- Malmö University has 3 upcoming primary-completion readouts tracked here; the soonest is “Clinical Performance of All-ceramic Posterior Crowns. A Randomized, Prospective Clinical.”, expected around 2020-02-01.